At Mitti Lifetek Medica, we focus on the world’s most overlooked health challenges, including missed diagnoses, untreated infections, unsafe clinical equipment, and gaps in access. We also address growing global and socioeconomic health threats through a One Health approach that recognises the critical connections between human health, dental and medical care environments, and the ecosystems we depend on.
In today’s unpredictable world, where health crises often carry far-reaching socioeconomic consequences, we harness over 40 years of combined expertise in biotechnology, AI, and clinical research to transform hidden challenges into breakthrough innovations. We deliver accessible, intelligent, and sustainable solutions that save lives, strengthen health systems, and empower communities to thrive.
From AI-enabled sterilisation to disease-specific oral health solutions, our technologies are accessible, intelligent, and sustainable — built to save lives, deliver measurable socioeconomic impact, and prepare healthcare systems for the challenges of today and tomorrow.
This is more than technology — it’s a movement for the future of One Health.
One breakthrough at a time: creating measurable impact for patients, value for stakeholders and actionable strategies for policymakers and healthcare providers worldwide.
Our vision and mission are united in one purpose: to empower safer healthcare and everyday hygiene through pioneering biotech and AI-driven solutions, transforming healthcare through innovations.
At Mitti Lifetek Medica, technology is more than innovation — it is purpose-driven problem solving. We design solutions at the intersection of biotechnology, artificial intelligence, and the One Health approach, recognising that human, animal, and environmental health are deeply interconnected.
Every product we create addresses a real-world challenge:
SteriPOC™ is a compact, portable, AI-driven tabletop sterilisation and disinfection system designed for speed, safety, and sustainability. Paired with our proprietary, eco-friendly SteriPOC™ disinfection liquid, it delivers hospital-grade sterilisation in clinics, dental practices, mobile health units, and emergency care settings.
The formulation not only prevents cross-infections but also disrupts and inhibits biofilm formation, ensuring a higher level of infection control. It is fully compatible with a wide range of surgical and dental instruments, preserving equipment integrity while maintaining proven antimicrobial efficacy — making infection prevention accessible anywhere.
SteriPOC™ reduces cross-infection risks, protects patients and healthcare staff, and enhances operational efficiency in any care setting. Fully adhering to WHO infection prevention and control guidelines, it enables rapid sterilisation and disinfection of surgical and dental instruments, helping healthcare providers lower hospital-acquired infection rates, extend the lifespan of critical equipment, and reduce long-term operational costs.
OralAura™ is a portfolio of clinically formulated, alcohol-free mouthwashes developed for patients whose medical conditions make oral health a vital part of their treatment and recovery. Over 2 billion high-risk individuals worldwide, including those fighting cancer, diabetes, tuberculosis and/or HIV/AIDS, cannot safely use conventional mouthwashes due to harmful chemicals and a lack of clinical validation. OralAura™ is designed to close this gap with safe, effective, and evidence-based solutions.
Our proprietary OralAura™ formulations combine anti-inflammatory agents, specialised enzymes for wound-healing and restricting oral biofilms, and soothing components to deliver comprehensive oral care. This targeted approach offers proven antimicrobial action, reduces inflammation, promotes healing, and helps prevent secondary infections that could delay or complicate treatment.
OralAura™ improves patient outcomes, prevents costly treatment complications, and supports better adherence to care plans. By reducing the burden of oral disease in high-risk populations, it strengthens health systems and advances a holistic approach to healthcare.
Bo Hammarlundwith 40+ years in R&D and innovation leadership at Ericsson, Bell Labs, and KTH, has published 50+ papers and secured 10+ patents while leading 100+ engineers in 15 companies. As Chairman, he provides governance and scale-up expertise, driving strategic growth with a proven track record in technology advancement.
Chairman & co-founder
Pavan Asalapuram a researcher with 20+ years of R&D and entrepreneurial experience, has generated €20M+, developed 8 patent families, and led multi-country clinical trials with 22 publications. He combines scientific rigor with commercial execution, steering Mitti Lifetek Medica toward global impact as CEO.
Founder & CEO
Kayathri Rajarathinam an angel investor with 10+ years in biomedical sciences, analytics, and AI, brings commercialization insights and AI-driven market adaptation strategies. Her expertise accelerates product development, leveraging her network to enhance Mitti Lifetek Medica’s market reach.
Co-founder
Ng Ee Xin with industry experience at Pfizer, P&G, and MDesign Solutions, excels in CAD, Python, C++, and lab analytics, earning awards for bridging engineering with biomedical applications. Her innovative research enhances Mitti Lifetek Medica’s product development, delivering cutting-edge solutions to real-world health challenges.
Research Engineer
Thomas Paulraj With a PhD, Thomas has 10+ years R&D, translational biotechnology and industry engineering, experience in Sweden, Germany, India.
Research Engineer
Prof. Anders Gustafsson former Vice Chancellor of Karolinska Institutet, managed a SEK 6B+ budget and 6,000 staff, authoring 200+ publications and advising WHO/EU. His global networks and governance expertise lend Mitti Lifetek Medica unmatched credibility and strategic direction to develop solutions for unmet need in oral sciences.
Fr. Vice President, Karolinska Institutet, Sweden
Prof. Georgios Tsilingaridis with 25+ years in pediatric dentistry, leads the Division of Orthodontics at Karolinska Institutet Hospital, impacting 10,000+ patients through innovative caries prevention and trauma care research. His global collaborations have reduced oral health disparities in underserved communities globally, enhancing diagnostic techniques with over 50 peer-reviewed publications.
Karolinska Institutet, Sweden
Prof. Alex Mira with 20 years leading oral microbiome research at FISABIO, has advanced personalized dental care, analyzing 5,000+ microbial samples to link periodontitis to microbial shifts. His work, cited in 200+ studies, has driven preventive strategies across the world through his innovations and contributions.
FISABIO Institute, Spain
Narayanan Srinivasan with 12 years in cognitive science at IIT Madras, has published 80+ papers, enhancing human-computer interaction for 5,000+ students and healthcare applications. His research, cited 500+ times, has improved educational tools bridging psychology and AI with a focus on attention studies.
IIT Madras, India
Prof. Cecilia Stålsby Lundborg with 30 years in global health, leads antibiotic resistance research at Karolinska Institutet, influencing policy for 50+ countries with 200+ publications. Her initiatives have improved healthcare access in low-resource settings, including medicines and policies with a special focus on antibiotic resistance impacting millions of lives across the globe.
Karolinska Institutet, Sweden
Martin Frisk with 18 years at SVEKON, oversees 50+ sustainable infrastructure projects in Scandinavia, delivering cost savings through innovative engineering solutions. His leadership has reduced environmental impact by 25% on key projects, managing teams of 200+ and securing contracts worth €50M annually.
Svensk Konstruktionstjänst, Sweden
We're here to answer your questions & explore new possibilities together.
Whether you're looking to collaborate, inquire about our products, or simply have a question — we're just a message away. Reach out to our team, and we'll get back to you with the information you need.
Contact
Address